Document Type
Oral Presentation
Location
Oxford Convention Center, 102 Ed Perry Boulevard Oxford, MS 38655
Event Website
https://oxfordicsb.org/
Start Date
16-4-2024 1:00 PM
End Date
16-4-2024 1:30 PM
Description
Nerium oleander is a well-known medicinal plant used in the Mediterranean region and traditional Indian medicine (Ayurveda) against a variety of diseases, including cancer. We investigated a cold-water extract of N. oleander leaves for their anticancer activities in vitro and in vivo. The cytotoxicity testing in the Oncotest panel of tumor cell lines and concomitant COMPARE analysis showed a high degree of similarity to mitosis-inhibiting compounds. We verified this hypothesis by treating tumor cells transfected with a tubulin-GFP fusion cDNA construct and confocal microscopy as well as a biochemical tubulin polymerization assay. N. oleander showed a similar inhibition of tubulin depolymerization as the control drug paclitaxel. Furthermore, the N. oleander extract inhibited the growth of human mammary cancer xenograft MAXF 401 alone (test/Control value 24%) in nude mice. In combination with paclitaxel, it effected a strong synergism in combination with paclitaxel resulting in complete remissions. A clinical phase I trial with breast or colon cancer patients showed tolerable side effects (fever, vomiting, nausea, diarrhea, fatigue). A subsequent clinical phase II trial with 300+ patients revealed tumor control rates (complete and partial remissions plus stabilizations) in a range of 8-70% in 18 different tumor types. Reference: Rashan LJ, Özenver N, Boulos JC, Dawood M, Roos WP, Franke K, Papasotiriou I, Wessjohann LA, Fiebig HH, Efferth T. Molecules. 2023;28(4):1871.
Recommended Citation
Efferth, Thomas; Rashan, Luay J.; Özenver, Nadire; Boulos, Joelle C.; Dawood, Mona; Roos, Wynand P.; Katrin, Katrin; Ioannis, Ioannis; Wessjohann, Ludger A.; and Fiebig, Heinz-Herbert, "Cold-water extract of Nerium oleander leaves inhibits cancer: From bench to bedside" (2024). Oxford ICSB. 16.
https://egrove.olemiss.edu/icsb/2024_ICSB/Schedule/16
Publication Date
April 2024
Accessibility Status
Searchable text
Included in
Cold-water extract of Nerium oleander leaves inhibits cancer: From bench to bedside
Oxford Convention Center, 102 Ed Perry Boulevard Oxford, MS 38655
Nerium oleander is a well-known medicinal plant used in the Mediterranean region and traditional Indian medicine (Ayurveda) against a variety of diseases, including cancer. We investigated a cold-water extract of N. oleander leaves for their anticancer activities in vitro and in vivo. The cytotoxicity testing in the Oncotest panel of tumor cell lines and concomitant COMPARE analysis showed a high degree of similarity to mitosis-inhibiting compounds. We verified this hypothesis by treating tumor cells transfected with a tubulin-GFP fusion cDNA construct and confocal microscopy as well as a biochemical tubulin polymerization assay. N. oleander showed a similar inhibition of tubulin depolymerization as the control drug paclitaxel. Furthermore, the N. oleander extract inhibited the growth of human mammary cancer xenograft MAXF 401 alone (test/Control value 24%) in nude mice. In combination with paclitaxel, it effected a strong synergism in combination with paclitaxel resulting in complete remissions. A clinical phase I trial with breast or colon cancer patients showed tolerable side effects (fever, vomiting, nausea, diarrhea, fatigue). A subsequent clinical phase II trial with 300+ patients revealed tumor control rates (complete and partial remissions plus stabilizations) in a range of 8-70% in 18 different tumor types. Reference: Rashan LJ, Özenver N, Boulos JC, Dawood M, Roos WP, Franke K, Papasotiriou I, Wessjohann LA, Fiebig HH, Efferth T. Molecules. 2023;28(4):1871.
https://egrove.olemiss.edu/icsb/2024_ICSB/Schedule/16
Comments
We gratefully acknowledge the stipend of the Sibylle Kalkhof-Rose-Foundation to J.C.B. and a stipend of the German Academic Exchange Service (DAAD) to N.Ö. Furthermore, we are grateful for the support of the Confocal Microscopy Facility of the Institute of Molecular Biology, Johannes Gutenberg University, Mainz, Germany